Newbury Pharmaceuticals AB (OSTO:NEWBRY) LT-Debt-to-Total-Asset : 0.00 (As of Nov. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Newbury Pharmaceuticals AB LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Newbury Pharmaceuticals AB's long-term debt to total assests ratio for the quarter that ended in Nov. 2024 was 0.00.

Newbury Pharmaceuticals AB's long-term debt to total assets ratio stayed the same from Nov. 2023 (0.00) to Nov. 2024 (0.00).

Newbury Pharmaceuticals AB LT-Debt-to-Total-Asset Historical Data

The historical data trend for Newbury Pharmaceuticals AB's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newbury Pharmaceuticals AB LT-Debt-to-Total-Asset Chart

Newbury Pharmaceuticals AB Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

LT-Debt-to-Total-Asset

Newbury Pharmaceuticals AB Quarterly Data
	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial												-	-	-	-	-

Newbury Pharmaceuticals AB LT-Debt-to-Total-Asset Calculation

Newbury Pharmaceuticals AB's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Aug. 2024 is calculated as

LT Debt to Total Assets (A: Aug. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Aug. 2024 )	/	Total Assets (A: Aug. 2024 )
	=	0	/	90.871
	=	0.00

Newbury Pharmaceuticals AB's Long-Term Debt to Total Asset Ratio for the quarter that ended in Nov. 2024 is calculated as

LT Debt to Total Assets (Q: Nov. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Nov. 2024 )	/	Total Assets (Q: Nov. 2024 )
	=	0	/	88.539
	=	0.00

Newbury Pharmaceuticals AB (OSTO:NEWBRY) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Newbury Pharmaceuticals AB LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.newburypharma.com

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Newbury Pharmaceuticals AB Headlines

No Headlines